Viral Response at Week 2 as a Predicitive Factor for Rvr in Chronic Hepatitis C Genotype 1 Infection Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)

被引：0
|
作者：
Mauss, Stefan
Lutz, Thomas
Boeker, Klaus H.
Link, Ralph
Moog, Gero
Stoehr, Albrecht D.
Baumgarten, Axel
Heyne, Renate
Eisenbach, Christoph
Teuber, Gerlinde
Weber, Bernd
Schott, Eckart
Hillenbrand, Heribert
Alshuth, Ulrich
Hueppe, Dietrich
Buggisch, Peter
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S958 / S958
页数：1
相关论文
共 50 条
  • [1] VIRAL RESPONSE AT WEEK 2 AS A PREDICITIVE FACTOR FOR RVR IN CHRONIC HCV GENOTYPE 1 INFECTION TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV)
    Mauss, S.
    Lutz, T.
    Boeker, K.
    Link, R.
    Moog, G.
    Stoehr, A.
    Baumgarten, A.
    John, C.
    Heyne, R.
    Eisenbach, C.
    Schiffelholz, W.
    Teuber, G.
    Weber, B.
    Schott, E.
    Hillenbrand, H.
    Alshuth, U.
    Hueppe, D.
    Buggisch, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S450 - S450
  • [2] POTENTIAL RELEVANCE OF VIRAL RESPONSE AT WEEK 8 AS A PREDICITIVE FACTOR FOR SVR IN GENOTYPE 1 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
    Mauss, Stefan
    Boeker, Klaus
    Zehnter, Elmar
    Schober, Andreas
    Moog, Gero
    Lutz, Thomas
    Schuchmann, Marcus
    Heyne, Renate
    Schiffelholz, Willi
    John, Christine
    Hey, Karl-Heinz
    Baumgarten, Axel
    Geyer, Peter R.
    Pape, Stefan
    Lohmeyer, Juergen
    Schmidt, Wolfgang
    Alshuth, Ulrich
    Hueppe, Dietrich
    HEPATOLOGY, 2010, 52 (04) : 777A - 777A
  • [3] Predicitive Factors for Nonresponse in Genotype 2/3 Infected Chronic Hepatitis C (CHC) Patients Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV) in Real Life Setting
    Petersen, Joerg
    Lutz, Thomas
    Link, Ralph
    Moog, Gero
    Baumgarten, Axel
    Schott, Eckart
    Schmidt, Wolfgang
    Witthoeft, Thomas
    Schnaitmann, Eiko
    Seidel, Matthias
    Rieke, Ansgar P.
    Simon, Karl Georg
    Herrmann, Andreas
    Herold, Christoph
    Klass, Dietmar M.
    Alshuth, Ulrich
    Buggisch, Peter
    Mauss, Stefan
    Hueppe, Dietrich
    GASTROENTEROLOGY, 2012, 142 (05) : S938 - S938
  • [4] Role of Rvr and Viral Load On SVR in Treatment of GT3 Hepatitis C Patients with Peginterferon Alfa-2a (PEG) and Ribavirin (RBV) in Real Life
    Zehnter, Elmar
    Hueppe, Dietrich
    Kaiser, Stephan
    Schober, Andreas
    Schuchmann, Marcus
    Boeker, Klaus
    Moog, Gero
    Schiffelholz, Willibold
    Pape, Stefan
    Heyne, Renate
    Ackermann, Frank
    Schmidt, Wolfgang
    John, Christine
    Lohmeyer, Juergen
    Hey, Karl-Heinz
    Alshuth, Ulrich
    Mauss, Stefan
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [5] ROLE OF RVR AND VIRAL LOAD ON SVR IN TREATMENT OF GT3 HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE
    Zehnter, E.
    Hueppe, D.
    Kaiser, S.
    Schober, A.
    Schuchmann, M.
    Boeker, K.
    Moog, G.
    Schiffelholz, W.
    Pape, S.
    Heyne, R.
    Ackermann, F.
    Schmidt, W.
    John, C.
    Lohmeyer, J.
    Hey, K. -H.
    Alshuth, U.
    Mauss, S.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S239 - S240
  • [6] PREDICTIVE FACTORS FOR NONRESPONSE IN GENOTYPE 2/3 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
    Petersen, J.
    Lutz, T.
    Link, R.
    Moog, G.
    Baumgarten, A.
    Schott, E.
    Schmidt, W.
    Witthoeft, T.
    Schnaitmann, E.
    Seidel, M.
    Rieke, A.
    Simon, K. G.
    Herrmann, A.
    Herold, C.
    Klass, D.
    Alshuth, U.
    Buggisch, P.
    Mauss, S.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S454 - S454
  • [7] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [8] A comparison of sustained viral response in patients with chronic hepatitis C virus (HCV) treated with peginterferon alfa-2a (Peg2a) versus peginterferon alfa-2b (Peg2b) and ribavirin
    Poordad, F
    Tran, TT
    Ayoub, W
    Patel, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S130 - S130
  • [9] Optimized virological response in genotype 4 chronic hepatitis C patients treated with peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin (RBV).
    Diago, M
    Hadziyannis, SJ
    Dunant, H
    Bodenheimer, H
    Hassanein, T
    Uchman, S
    Marcellin, P
    Ramadori, G
    Delwaide, J
    Sedarati, F
    HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [10] RETREATMENT WITH PEGINTERFERON (PEG-IFN) ALFA-2B PLUS RIBAVIRIN (RBV) OF CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS WHO WERE NONRESPONDERS TO PEGINTERFERON ALFA-2A: FINAL RESULTS OF ESPECIAL
    Zeuzem, Stefan
    Diago, Moises
    Pohle, Thorsten
    Andriulli, Angelo
    Spengler, Ulrich
    Gatta, Angelo
    Maieron, Andreas
    Herold, Christoph
    Yu, Xin
    Faruqi, Rab
    Chaudhri, Eirum I.
    Pedicone, Lisa
    HEPATOLOGY, 2009, 50 (04) : 684A - 685A
12345